Question 1

Does Woodline Partners own QNCX stock?

Accepted Answer

As of its Q1 2026 13F, Woodline Partners held 5,200,000 shares of QNCX (Quince Therapeutics), worth $527,280.

Question 2

How many shares of QNCX does Woodline Partners own?

Accepted Answer

As of its Q1 2026 13F, Woodline Partners held 5,200,000 shares of QNCX (Quince Therapeutics).

Question 3

What is Woodline Partners' QNCX position worth?

Accepted Answer

As of its Q1 2026 13F, Woodline Partners' QNCX position was worth $527,280.

Question 4

When did Woodline Partners first buy QNCX?

Accepted Answer

Woodline Partners first reported QNCX in its Q4 2025 13F and listed it in 2 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$18.19	0
2026-Q1	Increased	5.2M	+167.8%	$527,280	0.0%	$20.20	39
2025-Q4	New	1.9M	—	$6.5M	0.0%	$670.00	38